Therefore, we used BC cell lines, patient samples, public databases, and murine models to comprehensively explore the relevance between ENO1 and immune characteristics of BC and the efficacy of anti-PD-L1 therapy in BC. This evidence concerns the gene ENO1 and breast cancer.